Psychiatric and cognitive adverse events of eslicarbazepine acetate (ESL) monotherapy on adults with focal seizures: Results from a randomized, double-blind, active-controlled study and a 2-year open-label extension study

被引：0
作者：
Dupont, S. [1 ,2 ,3 ]
Fonseca, M. M. [4 ]
Fernandez, G. Castilla [4 ]
Ikedo, F. [4 ]
Pereira, A. [4 ]
Moreira, J. [4 ]
Gama, H. [4 ]
机构：
[1] UMPC, Hop Pitie Salpetriere, AP HP, Epilepsy Unit,CNRS,ICM,UMR 7225,UMRS 975,Inserm, Paris, France
[2] UMPC, Hop Pitie Salpetriere, AP HP, Rehabil Unit,CNRS,ICM,UMR 7225,UMRS 975,Inserm, Paris, France
[3] Univ Paris Sorbonne, Paris, France
[4] BIAL Portela Ca SA, Maia, Portugal
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
701
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [21] Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose-response study and open-label extension study
    Wada, Takashi
    Inagaki, Masaya
    Yoshinari, Toru
    Terata, Ryuji
    Totsuka, Naoko
    Gotou, Miki
    Hashimoto, Gaia
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (02) : 120 - 130
  • [22] SEIZURE FREEDOM AND PATIENT RETENTION WITH ADJUNCTIVE ESLICARBAZEPINE ACETATE THERAPY IN ADULTS WITH REFRACTORY PARTIAL SEIZURES DURING THREE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS WITH 1-YEAR, OPEN-LABEL EXTENSIONS
    Maia, J.
    Ben-Menachem, E.
    Elger, C.
    Gil-Nagel, A.
    Nunes, T.
    Soares-da-Silva, P.
    [J]. EPILEPSIA, 2010, 51 : 149 - 149
  • [23] EFFECT OF LURASIDONE ON COGNITIVE FUNCTION IN PEDIATRIC BIPOLAR DEPRESSION: RESULTS OF A 2-YEAR OPEN-LABEL EXTENSION STUDY
    Burdick, Katherine
    Tocco, Michael
    Pikalov, Andrei A.
    Deng, Ling
    Goldman, Robert S.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10) : S248 - S248
  • [24] Lipid profile with eslicarbazepine acetate and carbamazepine monotherapy in adult patients with newly diagnosed focal seizures: post hoc analysis of a phase III trial and open-label extension study
    Trinka, Eugen
    Rocamora, Rodrigo
    Chaves, Joao
    Koepp, Mathias J.
    Rueegg, Stephan
    Holtkamp, Martin
    Moreira, Joana
    Fonseca, Miguel M.
    Castilla-Fernandez, Guillermo
    Ikedo, Fabio
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [25] LONG-TERM EFFICACY AND TOLERABILITY OF GOLIMUMAB IN ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W. P.
    Braun, J.
    Bergman, G.
    Curtis, S. P.
    Tzontcheva, A.
    Philip, G.
    Huyck, S.
    Sieper, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 808 - 809
  • [26] LONG-TERM EFFICACY AND TOLERABILITY OF GOLIMUMAB IN ACTIVE NONRADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS OF THE OPEN-LABEL EXTENSION OF A RANDOMIZED, DOUBLE-BLIND STUDY
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W. P.
    Braun, J.
    Bergman, G.
    Curtis, S. P.
    Tzontcheva, A.
    Philip, G.
    Huyck, S.
    Sieper, J.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : 752 - 752
  • [27] Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study
    Brar, Indira
    Ruane, Peter J.
    Berhe, Mezgebe
    Brinson, Cynthia
    Benson, Paul
    Henry, Keith
    Liu, Hui
    Andreatta, Kristen
    Hindman, Jason T.
    Ramgopal, Moti
    [J]. MEDICINE, 2025, 104 (08) : e41482
  • [28] Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study
    Chung, Lorinda
    Silver, Richard M.
    Steen, Virginia
    Furst, Daniel E.
    Castelino, Flavia, V
    Trojanowski, Marcin
    Spiera, Robert
    Domsic, Robyn
    Rodriguez-Pla, Alicia
    Katsumoto, Tamiko R.
    Goulaouic, Helene
    Wang, Hong
    Espinasse, Melanie
    El-Chemaly, Souheil
    Wang, Rui
    [J]. RHEUMATOLOGY, 2025,
  • [29] LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE (ESL): RESULTS OF A ONE-YEAR OPEN-LABEL EXTENSION OF STUDY BIA-2093-303
    Lopes-Lima, J.
    Gil-Nagel, Antonio
    Maia, Joana
    Almeida, L.
    Soares-da-Silva, Patricio
    [J]. EPILEPSIA, 2008, 49 : 441 - 442
  • [30] Growth hormone deficiency and replacement therapy in Japan: Results of placebo-controlled double-blind study and open-label extension study
    Shimatsu, A.
    Tai, S.
    Kato, Y.
    Kohno, H.
    Tanaka, T.
    Teramoto, A.
    Chihara, K.
    [J]. DECADE OF HYPOCCS: THE CHANGING FACE OF PITUITARY DISEASE, 2008, 10 : 171 - +
12345